Evidence map›Paper›PMID 38065688›Full record

ArticleAnnals of medicine2023

Costs of abduction treatment in developmental dysplasia of the hip. Analysis of 900 patients.

Vilma Lankinen, Riikka-Liisa Vuorinen, Mika Helminen, Karim Bakti, Jarmo Välipakka, Hannele Laivuori, Anna Hyvärinen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Vilma LankinenDepartment of Pediatric Surgery, Turku University Hospital, Turku, Finland.ORCID 0000-0002-3374-8686
Riikka-Liisa VuorinenFaculty of Medicine and Health Technology, Tampere University, Finland.
Mika HelminenFaculty of Social Sciences, Health Sciences, Tampere University, Finland.
Karim BaktiFaculty of Medicine and Health Technology, Tampere University, Finland.
Jarmo VälipakkaPihlajalinna, Tampere, Finland.
Hannele LaivuoriDepartment of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland.ORCID 0000-0003-3212-7826
Anna HyvärinenFaculty of Medicine and Health Technology, Tampere University, Finland.
Tampere University · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDevelopmental dysplasia of the hip (DDH) is a disorder of hip development that leads to dysplasia, subluxation, or total hip dislocation. Early detection of DDH is important, and early initiation of abduction treatment is key to successful correction of the hip joint. However, mild forms of DDH, including hip instability without complete dislocation, have good spontaneous healing potential, and a watchful waiting strategy in mild DDH has been found to be safe. In this study, we aimed to evaluate the cost differences between different treatment strategies for DDH. MATERIAL AND

methodsData were collected retrospectively from the medical records of all children diagnosed with diagnosis and treatment of DDH in Tampere University hospital between 1998 and 2018. In total, 948 patients were included in the study. Patients who underwent casting or operative treatment (

resultsAlpha angles at one month of age (

conclusionWith correct patient selection, a watchful waiting strategy is cost-effective in treating mild developmental dysplasia of the hip, considering the high percentage of spontaneous recovery.

Indexed as

Developmental Dysplasia of the HipHip Dislocation, CongenitalChildEarly DiagnosisHumansInfantOrthotic DevicesRetrospective StudiesUltrasonographyabduction treatmentcost analysisDevelopmental dysplasia of the hipPavlik Harness

Identifiers

PMID38065688
PMCPMC10836239
OpenAlexW4389497457

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.